 |
|
Glioma Immunotherapy: Advances and Challenges for Spinal Cord Gliomas
Clare Grady, Kaitlyn Melnick, Ken Porche, Farhad Dastmalchi, Daniel J. Hoh, Maryam Rahman, Ashley Ghiaseddin
Neurospine. 2022;19(1):13-29. Published online 2022 Feb 2 DOI: https://doi.org/10.14245/ns.2143210.605
|
|
Citations to this article as recorded by
 Title: Immunotherapy; a ground-breaking remedy for spinal cord injury with stumbling blocks: An overview
Yasmeen Saeed
Frontiers in Pharmacology.2023;[Epub] CrossRef Delivering Glioblastoma a Kick—DGKα Inhibition as a Promising Therapeutic Strategy for GBM
Benjamin Purow
Cancers.2022; 14(5): 1269. CrossRef Another Milestone for Spinal Intramedullary Tumor Treatment
Chi Heon Kim
Neurospine.2022; 19(1): 30. CrossRef Atypical imaging features of the primary spinal cord glioblastoma: A case report
Xin-Yu Liang, Yao-Ping Chen, Qiao Li, Ze-Wang Zhou
World Journal of Clinical Cases.2022; 10(22): 7950. CrossRef The inhibitory effect of human umbilical cord mesenchymal stem cells expressing anti-HAAH scFv-sTRAIL fusion protein on glioma
Tian Xue, Xiaolin Wang, Jing Ru, Lixing Zhang, Huancai Yin
Frontiers in Bioengineering and Biotechnology.2022;[Epub] CrossRef Cuproptosis key gene FDX1 is a prognostic biomarker and associated with immune infiltration in glioma
Hanwen Lu, Liwei Zhou, Bingchang Zhang, Yuanyuan Xie, Huiyin Yang, Zhanxiang Wang
Frontiers in Medicine.2022;[Epub] CrossRef Current and Emerging Approaches for Spine Tumor Treatment
Bogdan Costăchescu, Adelina-Gabriela Niculescu, Bogdan Florin Iliescu, Marius Gabriel Dabija, Alexandru Mihai Grumezescu, Daniel Rotariu
International Journal of Molecular Sciences.2022; 23(24): 15680. CrossRef Two Cases of Primary Spinal Glioblastoma in Adults Treated With Multimodality Therapy
Ella Mae Cruz-Lim, François Germain, Delia Sauciuc, Benjamin Mou
Cureus.2022;[Epub] CrossRef
|